Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?

REFERENCES

1. 1.↵
   1. Tsokos GC

   . Systemic lupus erythematosus. N Engl J Med 2011;365:2110–21.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Arbuckle MR,
   2. McClain MT,
   3. Rubertone MV,
   4. Scofield RH,
   5. Dennis GJ,
   6. James JA,
   7. et al.

   Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526–33.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Lam GK,
   2. Petri M

   . Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2014;23 Suppl 39:S120–32.

   OpenUrl
4. 4.↵
   1. Kavanaugh A,
   2. Tomar R,
   3. Reveille J,
   4. Solomon DH,
   5. Homburger HA

   . Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71–81.

   OpenUrlPubMed
5. 5.↵
   1. Isenberg DA,
   2. Manson JJ,
   3. Ehrenstein MR,
   4. Rahman A

   . Fifty years of anti-ds DNA antibodies: are we approaching journey’s end? Rheumatology 2007;46:1052–6.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Pan N,
   2. Amigues I,
   3. Lyman S,
   4. Duculan R,
   5. Aziz F,
   6. Crow MK,
   7. et al.

   A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus 2014;23:293–8.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Linnik MD,
   2. Hu JZ,
   3. Heilbrunn KR,
   4. Strand V,
   5. Hurley FL,
   6. Joh T

   . Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:1129–37.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. ter Borg EJ,
   2. Horst G,
   3. Hummel EJ,
   4. Limburg PC,
   5. Kallenberg CG

   . Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990;33:634–43.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Cozzani E,
   2. Drosera M,
   3. Gasparini G,
   4. Parodi A

   . Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis 2014;2014:321359.

   OpenUrlPubMed
10. 10.↵
    1. Ho A,
    2. Barr SG,
    3. Magder LS,
    4. Petri M

    . A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:2350–7.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Giles BM,
    2. Boackle SA

    . Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunol Res 2013;55:10–21.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Swaak AJ,
    2. Groenwold J,
    3. Bronsveld W

    . Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986;45:359–66.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Hochberg MC

    . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Tan EM,
    2. Cohen AS,
    3. Fries JF,
    4. Masi AT,
    5. McShane DJ,
    6. Rothfield NF,
    7. et al.

    The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Petri M,
    2. Orbai AM,
    3. Alarcón GS,
    4. Gordon C,
    5. Merrill JT,
    6. Fortin PR,
    7. et al.

    Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–86.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Gladman DD,
    2. Ibañez D,
    3. Urowitz MB

    . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Man A,
    2. Shojania K,
    3. Phoon C,
    4. Pal J,
    5. de Badyn MH,
    6. Pi D,
    7. et al.

    An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol 2013;32:601–8.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Bonaguri C,
    2. Melegari A,
    3. Ballabio A,
    4. Parmeggiani M,
    5. Russo A,
    6. Battistelli L,
    7. et al.

    Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results. Autoimmun Rev 2011;11:1–5.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Solomon DH,
    2. Kavanaugh AJ,
    3. Schur PH;
    4. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines

    . Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434–44.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Faria AC,
    2. Barcellos KS,
    3. Andrade LE

    . Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol 2005;32:1267–72.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Tench CM,
    2. Isenberg DA

    . The variation in anti-ENA characteristics between different ethnic populations with systemic lupus erythematosus over a 10-year period. Lupus 2000;9:374–6.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Praprotnik S,
    2. Bozic B,
    3. Kveder T,
    4. Rozman B

    . Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren’s syndrome: a prospective study. Clin Exp Rheumatol 1999;17:63–8.

    OpenUrlPubMed
23. 23.↵
    1. Chow SL,
    2. Carter Thorne J,
    3. Bell MJ,
    4. Ferrari R,
    5. Bagheri Z,
    6. Boyd T,
    7. et al;
    8. Canadian Rheumatology Association Choosing Wisely Committee

    . Choosing wisely: the Canadian Rheumatology Association’s list of 5 items physicians and patients should question. J Rheumatol 2015;42:682–9.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Center for Medicaid & Medicare Services

    . Clinical Laboratory Fee Schedule 16CLAB Revised for January 2016. [Internet. Accessed February 2, 2018.] Available from: www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files.html
25. 25.↵
    1. Agarwal S,
    2. Harper J,
    3. Kiely PD

    . Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus. Lupus 2009;18:407–12.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Lateef A,
    2. Petri M

    . Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013;27:435–47.

    OpenUrlCrossRef
27. 27.↵
    1. Blomberg S,
    2. Ronnblom L,
    3. Wallgren AC,
    4. Nilsson B,
    5. Karlsson-Parra A

    . Anti-SSA/Ro antibody determination by enzyme-linked immunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening. Scand J Immunol 2000;51:612–7.

    OpenUrlCrossRefPubMed